S Supriya Lifescience Limited: management transactions · India · SEBI (PIT + SAST) SEBI:supriya-lifescience-limited IN IN · SEBI (PIT + SAST)
Browse the full directors' dealings record of Supriya Lifescience Limited, a listed equity based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). The latest transaction was reported on 27 February 2024 (Purchase). Among the most active insiders: Satish Waman Wagh. The full history is free.
Last declaration on 27 February 2024
Declarations 8 total
Executives ● Purchase0 SEBI
073,125 shares
Equity Shares
SEBI:66f1ae6324dbf2535b430f6982b1b78a69651074 · 26 Feb 2024
Ideal exit: 22 Nov 2024 (T+270) Executives ● Sale0 SEBI
073,125 shares
Equity Shares
SEBI:f0e1be029b7d879395d7c21223084cdefbca9b14 · 26 Feb 2024
Executives ● Purchase0 SEBI
€27,597 13,000 shares @ €2.1229
Equity Shares
SEBI:ad6317c156a07b97977355e156da8988abccf0b2 · 31 Mar 2023
Ideal exit: 26 Dec 2023 (T+270) Executives ● Purchase0 SEBI
€27,899 14,000 shares @ €1.9928
Equity Shares
SEBI:0f45231f935e903d70d879d68ef9fd39893704fc · 29 Mar 2023
Ideal exit: 24 Dec 2023 (T+270) Executives ● Purchase0 SEBI
€4,662 2,000 shares @ €2.3312
Equity Shares
SEBI:7d0a1a2b3b4c7ab910c9d13ab8c99ad2846d5604 · 3 Mar 2023
Ideal exit: 28 Nov 2023 (T+270) Executives ● Purchase0 SEBI
€18,650 8,000 shares @ €2.3312
Equity Shares
SEBI:942bd4b3d6b712c46ddee264e56a5ae9ebc64647 · 3 Mar 2023
Ideal exit: 28 Nov 2023 (T+270) Executives ● Purchase0 SEBI
€18,053 8,000 shares @ €2.2567
Equity Shares
SEBI:61ccd40f30820cdc8d03ad416bdd010469cadc04 · 28 Feb 2023
Ideal exit: 25 Nov 2023 (T+270) Executives ● Purchase0 SEBI
€4,513 2,000 shares @ €2.2567
Equity Shares
SEBI:ad17473ab9ff1ff8f679c082c9515d9b9e35d6b5 · 28 Feb 2023
Ideal exit: 25 Nov 2023 (T+270)